Correlation Between Pfizer and REYNOLDS
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and REYNOLDS AMERN INC, you can compare the effects of market volatilities on Pfizer and REYNOLDS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of REYNOLDS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and REYNOLDS.
Diversification Opportunities for Pfizer and REYNOLDS
Poor diversification
The 3 months correlation between Pfizer and REYNOLDS is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and REYNOLDS AMERN INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on REYNOLDS AMERN INC and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with REYNOLDS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of REYNOLDS AMERN INC has no effect on the direction of Pfizer i.e., Pfizer and REYNOLDS go up and down completely randomly.
Pair Corralation between Pfizer and REYNOLDS
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the REYNOLDS. In addition to that, Pfizer is 4.02 times more volatile than REYNOLDS AMERN INC. It trades about -0.23 of its total potential returns per unit of risk. REYNOLDS AMERN INC is currently generating about -0.16 per unit of volatility. If you would invest 9,958 in REYNOLDS AMERN INC on August 28, 2024 and sell it today you would lose (142.00) from holding REYNOLDS AMERN INC or give up 1.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. REYNOLDS AMERN INC
Performance |
| Timeline |
| Pfizer Inc |
| REYNOLDS AMERN INC |
Pfizer and REYNOLDS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and REYNOLDS
The main advantage of trading using opposite Pfizer and REYNOLDS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, REYNOLDS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in REYNOLDS will offset losses from the drop in REYNOLDS's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| REYNOLDS vs. The Coca Cola | REYNOLDS vs. JPMorgan Chase Co | REYNOLDS vs. Dupont De Nemours | REYNOLDS vs. Alcoa Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |